Protica Bio is redefining precision oncology with an AI-powered proteomics platform that delivers unmatched protein coverage (11,000+ proteins/sample) from minimal FFPE biopsies. Our lead diagnostic, ProteusDx™, outperforms PD-L1 with 86% PPV in Head & Neck cancer. Unlike genomics-based tools, Protica reveals dynamic, actionable protein signatures for immunotherapy response and novel drug target discovery, offering both diagnostic and therapeutic value in one scalable platform.